
Ritonavir‐boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta‐analysis
Author(s) -
Bierman WFW,
Humphreys EH,
Agtmael MA,
Boucher CA,
Rutherford GW
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-o18
Subject(s) - medicine , ritonavir , protease inhibitor (pharmacology) , antiretroviral therapy , combination therapy , pharmacotherapy , meta analysis , virology , pharmacology , human immunodeficiency virus (hiv) , viral load
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK